PharmAbcine Inc.

KOSDAQ:A208340 Voorraadrapport

Marktkapitalisatie: ₩88.0b

PharmAbcine Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jin-San Yoo

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO16.3yrs
Eigendom CEO0.9%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

PharmAbcine (KOSDAQ:208340) Has Debt But No Earnings; Should You Worry?

Mar 29
PharmAbcine (KOSDAQ:208340) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does PharmAbcine (KOSDAQ:208340) Use Debt?

Dec 14
Health Check: How Prudently Does PharmAbcine (KOSDAQ:208340) Use Debt?

CEO

Jin-San Yoo

16.3yrs

Tenure

Dr. Jin-San Yoo founded PharmAbcine Inc. in 2008 and serves as its Chief Executive Officer and President and serves as its President of R&D, CSO & CBO from March 2024 and served as its Director until March...